Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 3-ethoxy-4-hydroxy-, methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

97966-51-3

Post Buying Request

97966-51-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

97966-51-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 97966-51-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,9,6 and 6 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 97966-51:
(7*9)+(6*7)+(5*9)+(4*6)+(3*6)+(2*5)+(1*1)=203
203 % 10 = 3
So 97966-51-3 is a valid CAS Registry Number.

97966-51-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-ethoxy-4-hydroxy-benzoic acid methyl ester

1.2 Other means of identification

Product number -
Other names methyl 4-hydroxy-3-ethoxybenzoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:97966-51-3 SDS

97966-51-3Relevant academic research and scientific papers

Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives

-

Page/Page column 42, (2010/11/23)

This invention is concerned with compounds of the formula wherein A, B1, B2, R1, R2 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 97966-51-3